Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
News provided by
Share this article
Share this article
HELSINKI, April 21, 2021 /PRNewswire/ Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies.
The immediate product innovation target for the collaboration is to combine Nanoform s fast dissolution nanoformed particles with Aprecia s ZipDose
(TM) technology platform for rapid disintegration to enable high performance buccal and oral delivery of medicines to patients where rapid absorption is essential. Additional benefits may include lower dosage products, less excipient content, and reduced pi